Immunome (IMNM) FCF Margin (2023 - 2025)
Immunome (IMNM) posted FCF Margin of 1171.18% for Q2 2025, up 39.58% on a QoQ basis from 1938.48% in Q1 2025, and down 1590.0% year-over-year from 78.6% in Q2 2024.
Immunome (IMNM) FCF Margin (2023 - 2025) Analysis & Trends
Immunome's FCF Margin history runs 3 years deep, the most recent figure standing at 1171.18% for Q2 2025.
- Quarterly FCF Margin fell 1590.0% year-over-year to 1171.18% in Q2 2025, while the trailing twelve-month figure through Mar 2026 was 5118.9% (down 362939.0% YoY) and the FY2025 annual result came in at 2890.13%, down 158533.0% from the prior year.
- FCF Margin was 1171.18% for Q2 2025 at Immunome, up from 1938.48% in the prior quarter.
- Across five years, FCF Margin topped out at 1013.11% in Q1 2023 and bottomed at 1938.48% in Q1 2025.
- A 3-year average of 803.33% and a median of 1149.27% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin tumbled 215636 bps — and 2025, when it plunged 1590 bps.
- Immunome's FCF Margin stood at 457.81% in 2023, then tumbled by 245 bps to 1577.28% in 2024, then increased by 26 bps to 1171.18% in 2025.
- Business Quant data shows IMNM's FCF Margin at 1171.18% in Q2 2025, 1938.48% in Q1 2025, and 1577.28% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1,171.18% |
| Mar 31, 2025 | -1,938.48% |
| Dec 31, 2024 | -1,577.28% |
| Sep 30, 2024 | -1,227.01% |
| Jun 30, 2024 | -1,155.29% |
| Mar 31, 2024 | -1,143.25% |
| Dec 31, 2023 | -457.81% |
| Sep 30, 2023 | -237.95% |
| Jun 30, 2023 | -138.19% |
| Mar 31, 2023 | 1,013.11% |